Michael Kiernan to Angiotensin II Type 1 Receptor Blockers
This is a "connection" page, showing publications Michael Kiernan has written about Angiotensin II Type 1 Receptor Blockers.
Connection Strength
0.399
-
Kiernan MS, Wentworth D, Francis G, Martinez FA, Dickstein K, Komajda M, Zannad F, Neaton JD, Konstam MA. Predicting adverse events during angiotensin receptor blocker treatment in heart failure: results from the HEAAL trial. Eur J Heart Fail. 2012 Dec; 14(12):1401-9.
Score: 0.399